Health outcome | Lowest mean COHb for measured responsea (%) | Associated CO exposure | Response |
---|---|---|---|
Healthy subjects | |||
 Exercise-induced arrhythmias [44] | 5 [44] | 1000–3000 ppm for 4–6 min | No effect. |
3.95 (SD: 0.49) [31] | 100 ppm for 1 h | Decrease in mean exercise duration from 698 to 663 s (p < 0.001). | |
 Cardiovascular effects (cardiac output, heart rate, artery diameter, electrocardiogram changes) [25, 29, 33, 49, 89, 90] | 2.4 [33] | 15 ppm for 10 days (continuous exposure) | Electrocardiogram changes, specifically to p-waves, observed among three out of 15 subjects. |
3.95 (SD: 1.87) [25] | 5000 ppm for 2.5–3.5 min | Decrease in mean (sd) inspiratory capacity from 3655 (415) ml to 3380 (419) ml (p < 0.05), and total lung capacity from 7705 (1083) ml to 7545 (993) ml (p < 0.02). | |
5.1 (SD: 0.57) [34] | 74.1 ppm for 4 h | Decreases in performance of visual tracking exercises among high exposure group, compared with low exposure and control groups (p < 0.01). | |
 Cytokine production [48] | 7 (95% CI: 6.5,7.7) [48] | 500 ppm for 1 h | No effect. |
 Visual function [39] | 17.06 (SD: 1.38) [39] | 11,569 ppm for 4–5 min, followed by 141 ppm for 2 h | No effect. |
Susceptible groups | |||
Subjects with cardiovascular disease | |||
 Exercise-induced angina [53,54,55, 58,59,60,61,62,63, 66, 70] | 2.0 (SD: 0.05) [61] | 117 ppm for 50–70 min | Decrease in mean (sd) time to onset of angina from 501 (25) seconds to 482 (22) seconds (p = 0.054). |
5.91 (SD: 0.07) [65] | 200 ppm for 1 h | Higher frequency of single premature ventricular contractions per hour during exercise among subjects (p = 0.03). | |
2.0 (SD: 0.05) [61] | 117 ppm for 50–70 min | Decrease in mean (sd) length of time to a threshold ischemic ST-segment change from 576 (27) seconds to 510 (26) seconds (p < 0.0001). | |
 Cognitive function [57] | 3.90 [57] | 100 ppm, duration not reported | Decrease in mean performance of visualization test (p < 0.001), but no effects on performance of speed, flexibility, digit symbol, time perception, or reaction time tests. |
 Exercise-induced claudication (impairment, pain discomfort in legs) [56] | 2.77 [56] | 50 ppm for 2 h | Decrease in mean (sd) exercise time until onset of intermittent claudication from 174 (49) to 144 (38) seconds. |
Subjects with chronic obstructive pulmonary disease | |||
 Exercise performance [71] | 4.08 [71] | 100 ppm for 1 h | Decrease in mean (sd) exercise duration from 219 (48) to 147 (28) seconds (p < 0.001). |
Subjects with anemia | |||
 Exercise performance [72] | 3.38 (SD: 0.83) [72] | 50 ppm for 1 h | Decrease in mean (sd) exercise duration from 221 (72) to 217 (73) seconds (p < 0.0001). |
Subjects of older age (>  60 years) | |||
 Cognitive function [73] | 5.0 [73] | 200 ppm for 1 h and 50 ppm for 2 h | No effect. |